Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elly van Riet

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 18, 2015
Animal models for cutaneous vaccine deliveryHoang J H B Hirschberg, Elly van Riet, Dinja Oosterhoff, et al.
Journal of Immunology Research|March 1, 2017
Meta-Analysis of Pulmonary Transcriptomes from Differently Primed Mice Identifies Molecular Signatures to Differentiate Immune Responses following <i>Bordetella pertussis</i> ChallengeRené H M Raeven, Jeroen L A Pennings, Elly van Riet, et al.
Biomaterials|June 17, 2008
Synthesis, characterization and in vitro biological properties of O-methyl free N,N,N-trimethylated chitosanRolf J Verheul, Maryam Amidi, Steffen van der Wal, et al.
Human Vaccines & Immunotherapeutics|March 10, 2015
Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trialRenée A J van Boxtel, Pauline Verdijk, Otto J de Boer, et al.
Human Vaccines & Immunotherapeutics|January 18, 2020
<i>In silico</i> identification and modification of T cell epitopes in pertussis antigens associated with toleranceCorine Kruiswijk, Guilhem Richard, Merijn L M Salverda, et al.
Human Vaccines & Immunotherapeutics|July 31, 2013
Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adultsAkira Ainai, Shin-Ichi Tamura, Tadaki Suzuki, et al.
The Lancet. Infectious Diseases|March 21, 2026
Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmapElly van Riet, Björn Corleis, Birgitte K Giersing, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 26, 2009
Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulationsSuzanne M Bal, Bram Slütter, Elly van Riet, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 19, 2009
Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccinationBram Slütter, Laurence Plapied, Virgine Fievez, et al.
BMC Immunology|February 6, 2009
Combined TLR2 and TLR4 ligation in the context of bacterial or helminth extracts in human monocyte derived dendritic cells: molecular correlates for Th1/Th2 polarizationElly van Riet, Bart Everts, Kim Retra, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 18, 2015
Animal models for cutaneous vaccine deliveryHoang J H B Hirschberg, Elly van Riet, Dinja Oosterhoff, et al.
Journal of Immunology Research|March 1, 2017
Meta-Analysis of Pulmonary Transcriptomes from Differently Primed Mice Identifies Molecular Signatures to Differentiate Immune Responses following <i>Bordetella pertussis</i> ChallengeRené H M Raeven, Jeroen L A Pennings, Elly van Riet, et al.
Biomaterials|June 17, 2008
Synthesis, characterization and in vitro biological properties of O-methyl free N,N,N-trimethylated chitosanRolf J Verheul, Maryam Amidi, Steffen van der Wal, et al.
Human Vaccines & Immunotherapeutics|March 10, 2015
Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trialRenée A J van Boxtel, Pauline Verdijk, Otto J de Boer, et al.
Human Vaccines & Immunotherapeutics|January 18, 2020
<i>In silico</i> identification and modification of T cell epitopes in pertussis antigens associated with toleranceCorine Kruiswijk, Guilhem Richard, Merijn L M Salverda, et al.
Human Vaccines & Immunotherapeutics|July 31, 2013
Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adultsAkira Ainai, Shin-Ichi Tamura, Tadaki Suzuki, et al.
The Lancet. Infectious Diseases|March 21, 2026
Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmapElly van Riet, Björn Corleis, Birgitte K Giersing, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 26, 2009
Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulationsSuzanne M Bal, Bram Slütter, Elly van Riet, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 19, 2009
Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccinationBram Slütter, Laurence Plapied, Virgine Fievez, et al.
BMC Immunology|February 6, 2009
Combined TLR2 and TLR4 ligation in the context of bacterial or helminth extracts in human monocyte derived dendritic cells: molecular correlates for Th1/Th2 polarizationElly van Riet, Bart Everts, Kim Retra, et al.
Pageof 4